- AI² Robotics has completed 12 funding raises over the past year, with its valuation officially surpassing RMB 10 billion.
- AI² Robotics has completed its Series B financing round, raising over RMB 1 billion ($145 million).

Chinese general-purpose intelligent robotics company AI² Robotics has completed a Series B funding round exceeding RMB 1 billion ($145 million).
Chinese media outlet Jiemian first reported the funding on Monday, noting AI² Robotics' valuation has officially surpassed RMB 10 billion.
Investors in this round include Baidu Venture, CRRC Capital, Cedarlake Capital, Guotai Haitong Securities, multiple regional funds, and a publicly listed company within Tesla's supply chain.
AI² Robotics has completed 12 funding raises within the past year — including seven raises totaling hundreds of millions in the first half of 2025 alone. The Series B round saw five additional funding raises, making it the world's fastest-paced embodied intelligence company in terms of funding, Jiemian noted.
This rapid funding pace reflects the capital market's high enthusiasm for the humanoid robotics sector and positions AI² Robotics as a standout among peers.
Founded in April 2023 by Guo Yandong, AI² Robotics focuses on the R&D and mass production of AGI-native general-purpose intelligent robots.
Enabling robots to handle tasks that people don't want to do is the publicly said vision of AI² Robotics.
The company's core product, the AlphaBot series, is powered by its in-house developed embodied large model Alpha Brain and has achieved commercial deployment in semiconductor manufacturing, automotive manufacturing, electronics manufacturing, and biotechnology sectors.
In the automotive manufacturing sector, AI² Robotics signed a strategic cooperation agreement with Dongfeng Liuzhou Motor in June 2025.
The AlphaBot 2, equipped with its GOVLA (Global & Omni-body Vision-Language-Action) model, has officially entered automotive factories to handle tasks including labeling, assembly, and logistics transportation.
($1 = RMB 6.9087)